Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes

References

• Vinik AI Erbas T Park TS Methods for evaluation of peripheral neurovascular dysfunction Diabetes Technol Ther 2001 3 29 50 11469707
   PubMedGoogle Scholar
• Vinik A Erbas T Park T Stansberry K Scanelli J Pittenger G Dermal neurovascular dysfunction in type 2 diabetes Diabetes Care 2001 24 1468 1475 11473088
   PubMed Web of Science ®Google Scholar
• Holzer SE Camerota A Martens L Cuerdon T Crystal-Peters J Zagari M Costs and duration of care for lower extremity ulcers in patients with diabetes Clin Ther 1998 20 169 181 9522113
   PubMed Web of Science ®Google Scholar
• Lloret R Ycas J Stein M Haffner S Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial) Am J Cardiol 2006 98 768 773 16950182
   PubMed Web of Science ®Google Scholar
• Bullano MF Kamat S Wertz DA Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving lowdensity- lipoprotein cholesterol goals in a usual care setting Am J Health Syst Pharm 2007 64 276 284 17244877
   PubMed Web of Science ®Google Scholar
• Sergienko IV Samoilenko EI Masenko VP Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease Kardiologiia 2006 46 4 8 16858347
   PubMed Web of Science ®Google Scholar
• Cameron NE Eaton SEM Cotter MA Tesfaye S Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy Diabetologia 2001 44 1973 1988 11719828
   PubMed Web of Science ®Google Scholar
• Crouse JRIII Raichlen JS Riley WA Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial JAMA 2007 297 1344 1353 17384434
   PubMed Web of Science ®Google Scholar
• Nissen SE Nicholls SJ Sipahi I Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID Trial JAMA 2006 295 1556 1565 16533939
   PubMed Web of Science ®Google Scholar
• Medina RJ O’Neill CL Devine AB Gardiner TA Stitt AW The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies PLoS One 2008 3 e2584 18612412
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S Schmidt-Lucke C Bojunga S Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‚pleiotropic‘ functions of statin therapy Eur Heart J 2006 27 1182 1190 16621868
   PubMed Web of Science ®Google Scholar
• Mason JC Statins and their role in vascular protection Clin Sci (Lond) 2003 105 251 266 12793855
   PubMed Web of Science ®Google Scholar
• Bellosta S Via D Canavesi M HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages Arterioscler Thromb Vasc Biol 1998 18 1671 1678 9812903
   PubMed Web of Science ®Google Scholar
• Koh KK Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability Cardiovasc Res 2000 47 648 657 10974215
   PubMed Web of Science ®Google Scholar
• John S Schneider MP Delles C Jacobi J Schmieder RE Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients Am Heart J 2005 149 473 15864218
   PubMed Web of Science ®Google Scholar
• Cameron N Cotter M Inkster M Nangle M Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models Diabetes Res Clin Pract 2003 61 S35 S39 12880693
   PubMed Web of Science ®Google Scholar
• Pittenger G Simmons K Anandacoomaraswamy D Rice A Barlow P Vinik A Topiramate improves intraepidermal nerve fiber morphology and quantitative neuropathy measures in diabetic neuropathy patients. [abstract] J Peripher Nerve System 2005 10 Suppl 1
   Google Scholar
• Vinik A Erbas T Stansberry KB Pittenger G Small fiber neuropathy and neurovascular disturbances in diabetes mellitus Exp Clin Endocrinol Diabetes 2001 109 S451 S473 11460591
   PubMed Web of Science ®Google Scholar
• Stansberry KB Shapiro SA Hill MA McNitt PM Meyer MD Vinik AI Impaired peripheral vasomotion in diabetes Diabetes Care 1996 19 715 721 8799625
   PubMed Web of Science ®Google Scholar
• Saumet JL Kellogg DL Taylor WF Johnson JM Cutaneous laser-Doppler flowmetry: influence of underlying muscle blood flow J Appl Physiol 1998 65 478 481 3042745
   PubMed Web of Science ®Google Scholar
• Dyck PJ Detection, characterization and staging of polyneuropathy: assessed in diabetes Muscle Nerve 1988 11 21 32 3277049
   PubMed Web of Science ®Google Scholar
• Schafer RG Bohannon B Franz MJ Diabetes nutrition recommendations for health care institutions Diabetes Care 2004 27 Suppl 1 S55 S57 14693926
   PubMedGoogle Scholar
• Betteridge DJ Gibson JM Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes Diabet Med 2007 24 541 549 17367312
   PubMed Web of Science ®Google Scholar
• Rajpathak SN Kumbhani DJ Crandall J Barzilai N Alderman M Ridker PM Statin therapy and risk of developing type 2 diabetes: a meta-analysis Diabetes Care 2009 32 1924 1929 19794004
   PubMed Web of Science ®Google Scholar
• Smith AG Russell J Feldman EL Lifestyle intervention for prediabetic neuropathy Diabetes Care 2006 29 1294 1299 16732011
   PubMed Web of Science ®Google Scholar
• McCarty MF Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy Med Hypotheses 2002 58 476 486 12323113
   PubMed Web of Science ®Google Scholar
• Vinik AI Stansberry KB Barlow PM Rosiglitazone treatment increases nitric oxide production in human peripheral skin: a controlled clinical trial in patients with type 2 diabetes mellitus J Diabetes Complications 2003 17 279 285 12954157
   PubMed Web of Science ®Google Scholar
• Gulcan E Gulcan A Erbilen E Toker S Statins may be useful in diabetic foot ulceration treatment and prevention Med Hypotheses 2007 69 1313 1315 17499447
   PubMed Web of Science ®Google Scholar
• Vinik A Stansberry K Pioglitazone treatment improves nitrosative stress and microvascular function Diabetes 2003 52 Suppl 1 A478
   Google Scholar
• Chiquette E Ramirez G DeFronzo R A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors Arch Intern Med 2004 164 2097 2104 15505122
   PubMed Web of Science ®Google Scholar
• Goldberg RB Kendall DM Deeg MA A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia Diabetes Care 2005 28 1547 1554 15983299
   PubMed Web of Science ®Google Scholar
• Davis TM Bruce DG Davis WA Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: The Fremantle Diabetes Study Diabetes Res Clin Pract 2007 78 412 417 17645979
   PubMed Web of Science ®Google Scholar
• Gaede P Vedel P Larsen N Jensen G Parving H Pedersen O Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 2003 348 383 393 12556541
   PubMed Web of Science ®Google Scholar
• Keech AC Mitchell P Summanen PA Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial Lancet 2007 370 1687 1697 17988728
   PubMed Web of Science ®Google Scholar
• Nangle MR Cotter MA Cameron NE Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering Diabetes 2003 52 2396 2402 12941781
   PubMed Web of Science ®Google Scholar
• Stalker TJ Lefer AM Scalia R A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid Br J Pharmacol 2001 133 406 412 11375257
   PubMed Web of Science ®Google Scholar
• Pittenger G Mehrabyan A Simmons K Rice A Barlow P Vinik A Small fiber neuropathy is associated with the metabolic syndrome Metab Syndr Relat Disord 2005 3 113 121 18370718
   PubMed Web of Science ®Google Scholar